Beyond Tumors: Reduced survival linked to pathogenic PIK3CA and TP53 post-zygotic variants in uninvolved mammary tissue of breast cancer patients with recurrent disease
Andreou, M.; Chojnowska, K.; Filipowicz, N.; Horbacz, M.; Madanecki, P.; Duzowska, K.; Lawrynowicz, U.; Davies, H.; Bruhn-Olszewska, B.; Koszynski, M.; Drezek-Chyla, K.; Jaskiewicz, M.; Jakalski, M.; Kostecka, A.; Drzewiecka, M.; Nowikiewicz, M.; Las-Jankowska, M.; Bala, D.; Hoffman, J.; Srutek, E.; Szylberg, L.; Jankowski, M.; Jankau, J.; Hodorowicz-Zaniewska, D.; Szpor, J.; Zegarski, W.; Nowikiewicz, T.; Buckley, P. G.; Tiemann-Boege, I.; Mieczkowski, J.; Koczkowska, M.; Dumanski, J. P.; Piotrowski, A.
Show abstract
Histologically normal mammary tissue from breast cancer patients can harbor significant genetic alterations. We analyzed the spectrum of DNA variants in 408 matched histologically normal tissue and tumors from 77 poor-prognosis patients, 49 patients recruited without prognosis bias, and mammary gland samples from 15 non-cancerous individuals. Whole exome sequencing revealed a higher prevalence of pathogenic post-zygotic variants in cancer-associated genes: AKT1, PIK3CA, PTEN, TBX3, and TP53, affecting poor-prognosis patients (29%), compared to 12.5% in those without prognosis criteria (p=0.0008578). PIK3CA variants were recurrent across patients, while TP53 variants were restricted to those with adverse prognoses. Duplex sequencing detected low-frequency pathogenic PIK3CA and TP53 variants in distant normal tissues of poor-prognosis patients. Disease recurrence significantly reduced survival rates, with poor prognosis patients experiencing higher mortality within 24 months (p=0.0088), further worsened by the presence of pathogenic post-zygotic variants. These findings highlight the importance of genetic monitoring even in microscopically normal mammary tissue.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank 94%
- Impact of genetic counselling strategy on diagnostic yield and workload for whole genome sequencing-based tumour diagnostics 93%
- Classification of Variants of Reduced Penetrance in High Penetrance Cancer Susceptibility Genes: Framework for Genetics Clinicians and Clinical Scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK) 91%
Similar papers in this journal
- The French Early Breast Cancer Cohort (FRESH): a resource for breast cancer research and evaluations of oncology practices based on the French National Healthcare System Database (SNDS) 94%
- Genomic risk prediction for breast cancer in older women 94%
- APC Mutation marks an aggressive subtype of BRAF mutant colorectal cancers 93%
Similar papers in this journal
- Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes 96%
- Identifying therapeutic targets for cancer: 2,094 circulating proteins and risk of nine cancers 94%
- Influence of genetic ancestry on breast stromal cells provides biologic basis for increased incidence of metaplastic breast cancer in women of African descent 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.